(Q37072018)

18 August 2017

1 reference

title

Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent? (English)

1 reference

18 August 2017

1 reference

Katerina Kanková

1

1 reference

PubMed ID

18234133

18 August 2017

language of work or name

1 reference

1 February 2008

1 reference

Proceedings of the Nutrition Society

18 August 2017

1 reference

18 August 2017

67

1 reference

18 August 2017

60-74

1 reference

18 August 2017

1

1 reference

An abnormal hemoglobin in red cells of diabetics

18 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Advanced glycation end products in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

The AGE of the matrix: chemistry, consequence and cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease--a target for neuroprotective treatment strategies?

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS0029665108006034

21 January 2018

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Glycoxidation and lipoxidation in atherogenesis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

GAPDH as a sensor of NO stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Bioenergetics and the formation of mitochondrial reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Renal expression and localization of the facilitative glucose transporters GLUT1 and GLUT12 in animal models of hypertension and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Glucose transporters in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Characterisation of glucose transporters in the intact coronary artery endothelium in rats: GLUT-2 upregulated by long-term hyperglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Historical perspective of the Maillard reaction in food science

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Advanced glycation endproducts: what is their relevance to diabetic complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Level of an advanced glycated end product is genetically determined: a study of normal twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

RAGE-mediated MAPK activation by food-derived AGE and non-AGE products

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

ADME evaluation in drug discovery. 1. Applications of genetic algorithms to the prediction of blood-brain partitioning of a large set of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Nutrigenomics and nutrigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Advanced glycation end products and mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Glycoxidation and inflammation in renal failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Advanced glycation end products in clinical nephrology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Plasma levels of advanced glycation end products in children with renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Renal effects of oral maillard reaction product load in the form of bread crusts in healthy and subtotally nephrectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Metabolism of Maillard reaction products by the human gut microbiota--implications for health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Identification of a pathway for the utilization of the Amadori product fructoselysine in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Studies on absorption and elimination of dietary maillard reaction products

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): studies on the urinary excretion of pyrraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Metabolic transit and in vivo effects of melanoidins and precursor compounds deriving from the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Profound mishandling of protein glycation degradation products in uremia and dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Degradation of glycated bovine serum albumin in microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Impact of ageing on proteasome structure and function in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Protein degradation and protection against misfolded or damaged proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Advanced glycoxidation end products in commonly consumed foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Five years of research on health risks and benefits of Maillard reaction products: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Activation of tubular epithelial cells in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Development of an ELISA for esRAGE and its application to type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Tissue-specific expression patterns of the RAGE receptor and its soluble forms—a result of regulated alternative splicing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Advanced glycation end products and diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

The renin-angiotensin system and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Diabetic nephropathy: where hemodynamics meets metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Diabetic vascular disease: it's all the RAGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Understanding RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Scavenger receptors for oxidized and glycated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Genotoxicity of advanced glycation end products in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Depression of progenitor cell function by advanced glycation endproducts (AGEs): potential relevance for impaired angiogenesis in advanced age and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Effect of nonenzymatic glycation on functional and structural properties of hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Site-selective modifications of arginine residues in human hemoglobin induced by methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

The effects of the Maillard reaction on the physical properties and cell interactions of collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS0029665108006034

21 January 2018

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

The Functional -374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

Advanced glycation end products impair the scavenger function of rat hepatic sinusoidal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advanced glycation endproducts N epsilon-carboxymethyllysine (CML) and N epsilon-carboxyethyllysine (CEL).

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Renoprotection by blocking the RAAS in diabetic nephropathy—fact or fiction?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice

1 reference

https://api.crossref.org/works/10.1017%2FS0029665108006034

7 January 2021

10.1017/S0029665108006034

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18234133